Peptides Mimicking Structural Epitopes for Antibody Assays
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current medical diagnostic assays using protein arrays are costly, have limited chemical and thermal stability, and fail to adequately present the correct epitope structure, leading to weaker antibody binding due to the inability of linear peptides to fully occupy the antibody binding site, as most epitopes are not linear subsequences.
Innovation Solution
Design and synthesis of peptides that mimic structural epitopes by identifying and linking adjacent subsequences from protein structures, using amino acid linkers and cross-linking to replicate the three-dimensional structure of proteins, enhancing the affinity of antibody binding.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Stability of the object's composition
If short linear peptide subsequences are used in peptide arrays, then chemical stability and cost-effectiveness are improved, but the ability to present correct epitope structure deteriorates, leading to weaker antibody binding
Solution Approach 1:
The patent transitions from linear one-dimensional peptide sequences to three-dimensional folded structures. By designing peptides that fold back on themselves to create beta-sheet structures with antiparallel strands, the invention presents discontiguous amino acid sequences in spatial proximity, mimicking the native protein epitope architecture that antibodies recognize.
Solution Approach 2:
The patent introduces curvature and folding into linear peptide sequences by designing beta-hairpin structures with antiparallel strands. This curvature allows the peptide to form a three-dimensional binding surface that resembles the native protein epitope, enabling proper antibody recognition despite the peptide's synthetic origin.
2Ease of manufacture
If linear peptide sequences are used, then manufacturing simplicity and sequence diversity are improved, but the ability to occupy the antibody binding site fully deteriorates
Solution Approach 1:
The patent employs three-dimensional folding of linear peptides to create beta-sheet structures. This dimensional transformation allows the peptide to present multiple amino acid residues from different positions in the sequence simultaneously, effectively occupying the antibody binding site with a compact folded structure rather than requiring a long linear sequence.
Solution Approach 2:
The patent designs peptides where sequences nest back on themselves to form antiparallel beta-sheets. This nested arrangement allows distant amino acid residues in the linear sequence to come into close spatial proximity, creating a compact structure that efficiently occupies the antibody binding interface.
3Reliability
If protein arrays are used, then epitope structure accuracy is improved, but cost and chemical stability deteriorate
Solution Approach 1:
The patent creates simplified copies of native protein epitopes using short synthetic peptides that fold into structures mimicking the three-dimensional arrangement of amino acids in the native protein. These peptide copies retain the essential structural features of the epitope while being more stable and easier to manufacture than full-length proteins.
Solution Approach 2:
The patent changes the physical and chemical parameters of the epitope by using synthetic peptides with modified sequences designed to fold into stable beta-sheet structures. This allows the epitope to be presented in a more chemically stable form that resists degradation while maintaining the spatial arrangement necessary for antibody recognition.
Data Source
AI summary
A method including identifying one or more structures in adjacent sequences of one or more proteins that can be mimicked by a peptide; and assembling a peptide that mimics the one or more secondary structures. A method including assembling epitopes of linked pairs of discontiguous peptide subsequences that mimic one or more structures in sequences of a protein; and assaying antibodies against the epitopes.